PMID- 17578927 OWN - NLM STAT- MEDLINE DCOM- 20080115 LR - 20231212 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 104 IP - 26 DP - 2007 Jun 26 TI - Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. PG - 11097-102 AB - Circulating levels of the cytokine interleukin 18 (IL-18) are elevated in obesity. Here, we show that administration of IL-18 suppresses appetite, feed efficiency, and weight regain in food-deprived male and female C57BL/6J mice. Intraperitoneal vs. intracerebroventricular routes of IL-18 administration had similar potency and did not promote formation of a conditioned taste aversion (malaise-like behavior). Mice partially (Il18(+/-)) or totally (Il18(-/-)) deficient in IL-18 were hyperphagic by young adulthood, with null mutants then becoming overweight by the fifth month of life. Adult Il18(-/-) mice gained 2- to 3-fold more weight than WT mice per unit energy consumed of low- or high-fat diet. Indirect calorimetry revealed reduced energy expenditure in female Il18(-/-) mice and increased respiratory exchange ratios [volume of carbon dioxide production (VCO(2))/volume of oxygen consumption (VO(2))] in mutants of both sexes. Hyperphagia continued in maturity, with overeating greatest during the mid- to late-dark cycle. Relative white fat-pad mass of Il18(-/-) mice was approximately 2- to 3-fold greater than that of WT, with gonadal, mesenteric, and inguinal depots growing most. The data suggest that endogenous IL-18 signaling modulates food intake, metabolism, and adiposity during adulthood and might be a central or peripheral pharmacological target for controlling energy homeostasis. FAU - Zorrilla, Eric P AU - Zorrilla EP AD - Harold L. Dorris Neurological Research Institute, Committee on the Neurobiology of Addictive Disorders, and Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA. ezorrilla@scripps.edu FAU - Sanchez-Alavez, Manuel AU - Sanchez-Alavez M FAU - Sugama, Shuei AU - Sugama S FAU - Brennan, Molly AU - Brennan M FAU - Fernandez, Rosette AU - Fernandez R FAU - Bartfai, Tamas AU - Bartfai T FAU - Conti, Bruno AU - Conti B LA - eng GR - P30N5057096/PHS HHS/United States GR - AG28040/AG/NIA NIH HHS/United States GR - R21 DK077616/DK/NIDDK NIH HHS/United States GR - NS43501/NS/NINDS NIH HHS/United States GR - DK077616/DK/NIDDK NIH HHS/United States GR - R01 NS043501/NS/NINDS NIH HHS/United States GR - R01 AG028040/AG/NIA NIH HHS/United States GR - DK07118/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20070619 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Appetite Depressants) RN - 0 (Interleukin-18) SB - IM MH - Adiposity/drug effects MH - Age Factors MH - Animals MH - Appetite/*drug effects MH - Appetite Depressants MH - Eating/*drug effects MH - Energy Intake/*drug effects MH - Female MH - Homeostasis MH - Interleukin-18/genetics/*pharmacology/*physiology MH - Male MH - Metabolism/drug effects MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Overweight MH - Pulmonary Gas Exchange MH - Sex Factors PMC - PMC1904154 COIS- Conflict of interest statement: E.P.Z., B.C., M.S.-A., and T.B. have filed an invention disclosure regarding the use of IL-18 and related molecules to control energy homeostasis. EDAT- 2007/06/21 09:00 MHDA- 2008/01/16 09:00 PMCR- 2007/12/26 CRDT- 2007/06/21 09:00 PHST- 2007/06/21 09:00 [pubmed] PHST- 2008/01/16 09:00 [medline] PHST- 2007/06/21 09:00 [entrez] PHST- 2007/12/26 00:00 [pmc-release] AID - 0611523104 [pii] AID - 6835 [pii] AID - 10.1073/pnas.0611523104 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11097-102. doi: 10.1073/pnas.0611523104. Epub 2007 Jun 19.